[1]段 然.B超引导下宫腔镜电切术联合甲氨蝶呤治疗子宫切口瘢痕妊娠的可行性分析[J].医学信息,2021,34(03):134-135,138.[doi:10.3969/j.issn.1006-1959.2021.03.037]
　DUAN Ran.Feasibility Analysis of B-ultrasound Guided Hysteroscopic Resection Combined with Methotrexate in the Treatment of Uterine Incision Scar Pregnancy[J].Medical Information,2021,34(03):134-135,138.[doi:10.3969/j.issn.1006-1959.2021.03.037]
点击复制

B超引导下宫腔镜电切术联合甲氨蝶呤治疗子宫切口瘢痕妊娠的可行性分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年03期
页码:
134-135,138
栏目:
临床研究
出版日期:
2021-02-01

文章信息/Info

Title:
Feasibility Analysis of B-ultrasound Guided Hysteroscopic Resection Combined with Methotrexate in the Treatment of Uterine Incision Scar Pregnancy
文章编号:
1006-1959（2021）03-0134-03
作者:
段 然
（天津市河西区妇产科医院超声科，天津 300202）
Author(s):
DUAN Ran
(Department of Ultrasound,Obstetrics and Gynecology Hospital of Hexi District,Tianjin 300202,China)
关键词:
切口瘢痕妊娠; 宫腔镜电切术; 甲氨蝶呤
Keywords:
Incision scar pregnancy; Hysteroscopic resection; Methotrexate
分类号:
R714.22；R719
DOI:
10.3969/j.issn.1006-1959.2021.03.037
文献标志码:
A
摘要:
目的 探讨B超引导下宫腔镜电切术联合甲氨蝶呤治疗子宫切口瘢痕妊娠患者的可行性。方法 按照随机数字表法将2016年1月~2018年12月我院接受治疗的80例切口瘢痕妊娠患者分为两组，每组40例。对照组行甲氨蝶呤联合负压吸引清宫术治疗，研究组行B超引导下宫腔镜电切术与甲氨蝶呤治疗，比较两组治疗情况、预后及术后并发症情况。结果 研究组手术时间、术后阴道流血时间、住院时间、月经周期恢复时间、血β-hCG水平恢复时间均短于对照组（P＜0.05）；研究组的术中出血量为（33.00±7.01）ml，少于对照组的（83.00±7.98）ml（P＜0.05）；研究组随访1年内妊娠率和顺产率为82.50%、67.50%，高于对照组的35.00%和37.50%；剖宫产率为5.00%，低于对照组的40.00%（P＜0.05）；研究组术后并发症率为2.50%，低于对照组的25.00%（P＜0.05）。结论 B超引导下宫腔镜电切术与甲氨蝶呤治疗切口瘢痕妊娠，治疗效果确切，有助于提高妊娠率与顺产率，降低剖宫产率，减少术后并发症的发生。
Abstract:
Objective To investigate the feasibility of B-ultrasound guided hysteroscopic resection combined with methotrexate in the treatment of uterine incision scar pregnancy patients.Methods According to the random number table method, 80 patients with incision scar pregnancy who received treatment in our hospital from January 2016 to December 2018 were divided into two groups, each with 40 cases.The control group underwent methotrexate combined with negative pressure suction uterine evacuation treatment, and the study group underwent B-ultrasound guided hysteroscopy and methotrexate treatment. The treatment, prognosis and postoperative complications of the two groups were compared.Results The operation time, postoperative vaginal bleeding time, hospitalization time, menstrual cycle recovery time, and blood β-hCG level recovery time in the study group were shorter than those in the control group(P＜0.05);The intraoperative blood loss in the study group was (33.00±7.01) ml, which was less than (83.00±7.98) ml in the control group(P＜0.05);The pregnancy rate and delivery rate within 1 year of the study group were 82.50% and 67.50%, which were higher than 35.00% and 37.50% of the control group; the cesarean section rate was 5.00%, which was lower than 40.00% of the control group(P＜0.05);The postoperative complication rate in the study group was 2.50%, which was lower than the 25.00% in the control group(P＜0.05).Conclusion B-ultrasound guided hysteroscopic resection and methotrexate in the treatment of incision scar pregnancy have a definite therapeutic effect, which is helpful to increase pregnancy rate and cistern birth rate, reduce cesarean section rate, and reduce postoperative complications.

参考文献/References:

[1]王和坤.甲氨蝶呤、米非司酮联合宫腔镜电切术在剖宫产术后子宫瘢痕妊娠治疗中的应用[J].中国当代医药,2011,18(36):54-55. [2]王爱丽,陈彦辛,曹立花.宫腔镜电切术联合宫外孕Ⅱ号方及甲氨蝶呤治疗剖宫产瘢痕妊娠的观察[J].海南医学院学报,2018,24(10):15-19. [3]杨益,张力尹,陈艳.米非司酮及米索前列醇联合宫腔镜切除内生型子宫下段剖宫产切口瘢痕处妊娠的疗效[J].中国医师杂志,2018,20(11):88-91. [4]黄香莲.米非司酮联合甲氨蝶呤治疗剖宫产瘢痕妊娠的临床疗效[J].临床合理用药杂志,2018,11(25):102-103. [5]Pedraszewski P,Wlazlak E,Panek W,et al.Cesarean scar pregnancy - a new challenge for obstetricians[J].J Ultrason,2018,18(72):56-62. [6]杨庆彪,张婷,陆燕,等.甲氨蝶呤联合米非司酮及宫外孕2号方加味治疗剖宫产子宫切口瘢痕妊娠疗效观察[J].现代中西医结合杂志,2018,27(2):54-56. [7]李彦曦,黄勇,刁蓉.子宫动脉栓塞联合宫腔镜治疗子宫切口瘢痕妊娠的临床价值分析[J].解放军医药杂志,2018,30(6):61-63. [8]Xiao Z,Cheng D,Chen J,et al.The effects of methotrexate and uterine arterial embolization in patients with cesarean scar pregnancy:A retrospective case-control study[J].Medicine,2019,25(21):141-147. [9]包义明,汪洋.高强度聚焦超声消融治疗子宫切口瘢痕妊娠的疗效分析[J].临床超声医学杂志,2018,20(11):64-66. [10]董艳霞.甲氨蝶呤米非司酮口服联合宫腔镜电切术治疗子宫切口瘢痕妊娠[J].中国妇幼保健,2018,33(15):3494-3496. [11]Wang S,Beejadhursing R,Ma X,et al.Management of Caesarean scar pregnancy with or without methotrexate before curettage:human chorionic gonadotropin trends and patient outcomes[J].BMC Pregnancy and Childbirth,2018,18(1):289-291. [12]阮璐璐.超声介入引导下甲氨蝶呤局部注射联合口服米非司酮治疗子宫瘢痕妊娠的疗效观察[J].蚌埠医学院学报,2019,44(9):1230-1233. [13]杨庆彪,张婷,陆燕,等.甲氨蝶呤联合米非司酮及宫外孕2号方加味治疗剖宫产子宫切口瘢痕妊娠疗效观察[J].现代中西医结合杂志,2018,27(2):54-56. [14]徐虹,汪龙霞,罗渝昆,等.甲氨蝶呤局部注射联合米非司酮口服治疗剖宫产切口瘢痕妊娠的临床研究[J].中国药物应用与监测,2016(4):197-200.

相似文献/References:

[1]谢佳佳,纪燕琴,周明辉.自交联透明质酸钠预防宫腔镜术后宫腔粘连的效果观察[J].医学信息,2018,31(16):51.[doi:10.3969/j.issn.1006-1959.2018.16.014]
　XIE Jia-jia,JI Yan-qin,ZHOU Ming-hui.Effect of Self-crosslinking Sodium Hyaluronate on Prevention of Intrauterine Adhesion after Hysteroscopic Surgery[J].Medical Information,2018,31(03):51.[doi:10.3969/j.issn.1006-1959.2018.16.014]
[2]李岩华.宫腔镜电切术治疗子宫内膜息肉患者的效果[J].医学信息,2021,34(13):131.[doi:10.3969/j.issn.1006-1959.2021.13.035]
　LI Yan-hua.Effect of Hysteroscopic Electric Resection on Patients with Endometrial Polyps[J].Medical Information,2021,34(03):131.[doi:10.3969/j.issn.1006-1959.2021.13.035]
[3]李岩华.宫腔镜电切术联合孕激素治疗早期孕激素受体阳性子宫内膜癌的疗效[J].医学信息,2021,34(14):133.[doi:10.3969/j.issn.1006-1959.2021.14.036]
　LI Yan-hua.Efficacy of Hysteroscopic Resection Combined with Progesterone in the Treatment of Early Progesterone Receptor-positive Endometrial Carcinoma[J].Medical Information,2021,34(03):133.[doi:10.3969/j.issn.1006-1959.2021.14.036]
[4]林 苗,余怡红.宫腔镜电切术联合左炔诺孕酮宫内缓释系统的临床疗效分析[J].医学信息,2022,35(22):121.[doi:10.3969/j.issn.1006-1959.2022.22.027]
　LIN Miao,YU Yi-hong.Analysis of Clinical Efficacy of Transcervical Resection Of Endometrialpolyps Combined with Levonorgestrel Intrauterine Sustained Release System[J].Medical Information,2022,35(03):121.[doi:10.3969/j.issn.1006-1959.2022.22.027]

更新日期/Last Update: 1900-01-01